Evidence map›Paper›PMID 24445950›Full record

ArticleMolecular neurobiology2014

PAS kinase is a nutrient and energy sensor in hypothalamic areas required for the normal function of AMPK and mTOR/S6K1.

Verónica Hurtado-Carneiro, Isabel Roncero, Sascha S Egger, Roland H Wenger, Enrique Blazquez, Carmen Sanz, Elvira Alvarez

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Insights into the role of neuronal glucokinase.American journal of physiology. Endocrinology and metabolism · 2016
    Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Verónica Hurtado-CarneiroDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, Complutense University, Plaza S. Ramón y Cajal, s/n, Madrid, 28040, Spain, verohur@med.ucm.es.
Isabel Roncero
Sascha S Egger
Roland H Wenger
Enrique Blazquez
Carmen Sanz
Elvira Alvarez
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESSwiss Integrative Center for Human Health · CHUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complications caused by overweight, obesity and type 2 diabetes are one of the main problems that increase morbidity and mortality in developed countries. Hypothalamic metabolic sensors play an important role in the control of feeding and energy homeostasis. PAS kinase (PASK) is a nutrient sensor proposed as a regulator of glucose metabolism and cellular energy. The role of PASK might be similar to other known metabolic sensors, such as AMP-activated protein kinase (AMPK) and the mammalian target of rapamycin (mTOR). PASK-deficient mice resist diet-induced obesity. We have recently reported that AMPK and mTOR/S6K1 pathways are regulated in the ventromedial and lateral hypothalamus in response to nutritional states, being modulated by anorexigenic glucagon-like peptide-1 (GLP-1)/exendin-4 in lean and obese rats. We identified PASK in hypothalamic areas, and its expression was regulated under fasting/re-feeding conditions and modulated by exendin-4. Furthermore, PASK-deficient mice have an impaired activation response of AMPK and mTOR/S6K1 pathways. Thus, hypothalamic AMPK and S6K1 were highly activated under fasted/re-fed conditions. Additionally, in this study, we have observed that the exendin-4 regulatory effect in the activity of metabolic sensors was lost in PASK-deficient mice, and the anorexigenic properties of exendin-4 were significantly reduced, suggesting that PASK could be a mediator in the GLP-1 signalling pathway. Our data indicated that the PASK function could be critical for preserving the nutrient effect on AMPK and mTOR/S6K1 pathways and maintain the regulatory role of exendin-4 in food intake. Some of the antidiabetogenic effects of exendin-4 might be modulated through these processes.

Indexed as

AMP-Activated Protein KinasesAnimalsDiabetes Mellitus, Type 2EatingEnergy MetabolismExenatideGlucagon-Like Peptide 1HomeostasisHypothalamusMaleMice, Inbred C57BLPeptidesProtein Serine-Threonine KinasesRibosomal Protein S6 Kinases, 90-kDaSignal TransductionTOR Serine-Threonine KinasesAMP-Activated Protein KinasesExenatideGlucagon-Like Peptide 1mTOR protein, mousePAS domain kinasesPeptidesProtein Serine-Threonine KinasesRibosomal Protein S6 Kinases, 90-kDaRps6ka1 protein, mouseTOR Serine-Threonine KinasesVenoms

Identifiers

PMID24445950
OpenAlexW1973080083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.